chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Days after receiving the vaccine, my arm was swelling and felt numb. I informed my wife who noticed my speech was slurred and stuttered. She took me to the emergency room; they diagnosed me with a heart attack. I was transported to the nearest medical center and put into ICU to be monitored overnight on 01/08/2023. The next morning, the neurosurgeon examined my test results including MRI scans, CT scans, bloodwork, and heart rate panel and confirmed I was suffering from a PIA (post-infarction angina) and put me on a temporary prescription of PLAVIX.
2nd H1N1 vaccine admin. 01/15/10. Temp >100 on 1/16/10 d/c 1/19/10. Full body hives 1/17/10->dc 01/18/10.
Headache, Myalgia, NauseaVomiting, Injection site warm and swollen, fatigue, hot and cold flashes Narrative:
Patient woke up the morning after her flu shot with left arm paresis.  She could not move or feel her arm, except for a great deal of pain in her shoulder and and upper back.  She was admitted to the hospital on 11/15/11, stayed two nights and began to regain movement in her arm (but not sensation).  The numbness has since progressed (as of 11/29/11) throughout the left side of her body:  up to her cheek and down to her fingers; and from her hip to just above her ankle in her left leg.  Her left foot experiences intermittent tingling.  She had to have an LP to test for Guillain-Barre, which though negative, has resulted in back pain, headaches persistent nausea.
pt recv vax & lab tests revealed negative rubella antibody titer;pt had nl mumps skin test & nl tetanus response indicating an intact immune response;
I became pregnant 01/10 that was the start of the pregnancy I was 6 weeks a long I went in on 03/22/2023 I had a missed, missed carriage. I had all early pregnancy symptoms even though pregnancy had been ended. I went to Hospital and had to have A DNC on 03/23/2023
Information has been received from a health professional concerning her 10 week old son who was vaccinated with a first dose of Rotavirus vaccine. Subsequently the pt experienced constipation. No product quality complaint was involved. Additional information is not expected.
After my shot, I expected some reaction or maybe none.  Then in about a months time I was getting headaches in the back of my head and then to the front like a migraine.  Never had headaches at all for all my years.  But, then more intense headaches on top of my head , tight ness in back of my head. I began to get very concerned!. Blood clot? Stroke? I called the Neurologist and made an appointment. I had to take 500mg of Tylenol and then went to 1,000 mg. and lay down . the pain was getting worse. in the a.m. then in the p.m. all day!
I developed a fever spanning from 99.4-101.7, and extreme fatigue, body chills, overall malease. This occurred around 5 days to a week after the vaccine. This occurred for a month, until I was placed on steroids. During this time period, I visited the hospital emergency room twice, and I also saw my primary care doctor, as well as an outpatient doctor, as well as a infectious disease specialist. I was treated with essentially nothing until we were able to rule out all of the causes of this reaction. The decision was then made to put me on steroids, because the next viable option was that I was having a significant immune response to the vaccine. This was a medal pack, I took the pack twice and afterwards I felt a lot better and my fever was gone.
Localized reaction to left thigh after flu vaccine was given. Red and swollen. 1/2 tsp of BENADRYL was given and had patient wait in our office for 20 mins.
Symptom: Headache | Treatment: Tylenol | Outcome: No resolution thus far; Symptom: Fatigue | Treatment: Sleep | Outcome: Slight improvement in fatigue; Symptom: Left arm muscle soreness (same arm as injection) | Treatment: Tylenol | Outcome: No resolution thus far; and Symptom: Back pain (upper-left quadrant) | Treatment: Stretching and Tylenol | Outcome: No resolution thus far
Loratadine histamine for allergic reaction And RX for hydrocodone 2.5%
(L) shoulder pain, decreased ROM. (L) arm pain - triceps area, but not the actually site of injection. No redness or swelling, just tenderness, achiness.
HOT FLASHES; BODY ACHES; CHILLS; NAUSEA; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection. The patient could breath normally again on the upside of his lungs, sinuses weren't as bad, could taste again. The patient received covid-19 vaccine (suspension for injection, route of admin not reported,) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be required for this case. No concomitant medications were reported. On an unspecified date, the subject experienced hot flashes, body aches, chills, and nausea. The action taken with covid-19 vaccine  was not applicable. The outcome of the hot flashes, chills, nausea and body aches was not reported. This report was non-serious.
Watery eyes, runny nose. Allergy like symptoms but typically don't have allergies. Also don't feel like I have cold.
1st dose two years ago, 2nd not received; This case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a 64-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix  (received a dose of Shingrix two years ago ).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 11-Oct-2022 Reporter's comment: The pharmacist reported that the patient never got the second dose. The reporter did not consent to follow-up. Additional supportive information: Till the time of reporting, the patient did not receive second dose of Shingrix, which led to incomplete course of vaccination.
R arm pain and swelling post flu and pnemovax injections warm to touch. Sx noted after 24 hrs of injections- local reaction.
arm was swollen; slight chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of VACCINATION SITE SWELLING (arm was swollen) and CHILLS (slight chills) in a 75-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.  On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 04-Feb-2021, the patient experienced VACCINATION SITE SWELLING (arm was swollen) and CHILLS (slight chills). At the time of the report, VACCINATION SITE SWELLING (arm was swollen) and CHILLS (slight chills) had resolved. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.   This case was linked to MOD-2021-035929 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 02-May-2021: NNI
At 8 hours after vaccination patient awoke with severe chills, diarrhea, nausea, body aches "felt like flu".
Right after vaccines - became pale, developed tonic clonic sz lasting about 3 min. Heart rate normal O2 Sats nl. Postictal period after about 20-30 min.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 09-OCT-2015, the patient was vaccinated with improperly stored RECOMBIVAX HB (exposed to the following temperatures and cumulative time frames colder than 36F: In September of 2015, the coldest temperature was 34F for 346.7 hours (over 14 days); In October of 2015, the coldest temperature was 34F for 492.6 hours for a total of 839.3 hours (35 days); In November of 2015, the coldest temperature was 34F for 192 hours, for a total of 1,031.3 hours (43 days)) with lot number: L001456, expiry date: 22-OCT-2016 (dose and strength unspecified). No concomitant medications were reported. No adverse effects were reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of the several reports from the same reporter. Additional information has been requested.
This spontaneous report was received from a pharmacist refers to a 66 year old female patient who did not have pertinent medical history, drug reactions or allergies. On 05-FEB-2013, the patient was vaccinated with ZOSTAVAX (lot # H019998; exp 20-FEB-2014), subcutaneous for shingles prevention (dose not provided). No concomitant medication was reported. On 06-FEB-2013, the patient developed "redness, heat and swelling the size of a grapefruit from her shoulder down to her elbow, 1 to 2 days after administration of ZOSTAVAX. The patient's unspecified physician treated the reaction with ZYRTEC. It was reported that the patient's arm was "getting better" but that it was now "peeling and flaky". Laboratories were not performed. At the time of the report, the outcome of redness, heat and swelling was reported as recovering/resolving. The outcome of peeling and flaky is unknown. The events of redness, heat and swelling, peeling and flaky was unknown related to ZOSTAVAX. Additional information has been requested.
This spontaneous report as received from a physician refers to an unspecified number of patients of unknown demographics. No patients' concurrent conditions or medical history were provided. On an unknown date, these patients were vaccinated with improperly stored doses of GARDASIL 9 injection (lot # M003659 with expiry date: 20-SEP-2017; strength, dose, route and site of administration were unspecified). The administered vaccine underwent the temperature excursion at 30 degrees Fahrenheit for 30 days. There was no previous temperature excursion. It was a case of a "data logger". No concomitant medications were reported. No adverse effect was reported. This is one of several reports from the same source. Additional information has been requested.
This case was reported by a nurse via sales rep and described the occurrence of syncope in a patient who received BEXSERO. On an unknown date, the patient received BEXSERO .5 ml. On an unknown date, several minutes after receiving BEXSERO, the patient experienced syncope. On an unknown date, the outcome of the syncope was unknown. The reporter considered the syncope to be almost certainly related to BEXSERO. Additional details were provided as follows: This case was previously reported to a doctor. The age at vaccination as not reported. The patient did not receive any concomitant medication. At an event booth, the nurse practitioner reported to the sales representative that she had a patient who received BEXSERO in the office and within minutes experienced syncope. All questions were asked to the sales representative, but he had minimal information.
Body aches, maliase, feeling bad.  Drank fluids, took Advil/Tylenol. Rested.
infected with Covid after receiving her two dose series Of Pfizer bioNTech COVID-19 vaccine; infected with Covid after receiving her two dose series Of Pfizer bioNTech COVID-19 vaccine; Fatigue; Cough; Stuffy nose; Headache; This is a spontaneous report received from non-contactable reporter (nurse) from a sales representative. The reporter is the patient.  A female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose 2, single and (Batch/Lot number: unknown) as dose 1, single for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant) and COVID-19 (medically significant), outcome "unknown" and all described as "infected with Covid after receiving her two dose series Of Pfizer bioNTech COVID-19 vaccine"; FATIGUE (non-serious), outcome "unknown", described as "Fatigue"; COUGH (non-serious), outcome "unknown", described as "Cough"; NASAL CONGESTION (non-serious), outcome "unknown", described as "Stuffy nose"; and HEADACHE (non-serious), outcome "unknown", described as "Headache". Clinical course: The time from last dose was unknown. She was not able to get her booster prior to the infection  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on limited information in the case  a possible causal association between the reported  events Drug ineffective, Covid-19  and the suspect drug BNT162B2 cannot be excluded.
Initial report received on 27 Oct 2005 from a health care professional. A 3 year old male child with no known allergies, history of asthma, failure to thrive and general abscess presented with eyes almost swollen shut few hours after the intramuscular influenza vaccine, lot no: U1838AA administration in the right thigh on 27 Oct 2005. The patient was seen by a physician, Benadryl was ordered. It was reported that the patient had a previous dose of the same vaccine last year. No other symptoms were reported. Patient's conditon got improved and he recovered at the time of the report. Follow up information received on 30/Jan/2006. Per the reporter, the patient had received an injection of Fluzone on 07/Feb/2005 and did not experience any reactions. At the time of the vaccination, the patient had Asthma, failure to thrive and a dental abscess. Patient was taking Amoxil for the dental abcess at the time of the vaccination. The patient experienced swollen eyes 30 minutes post vaccination and was treated for this with Benadryl 5mg/kg every six hours for 24 hours. No further information is expected.
Initial misuse report received from a healthcare professional on 09 August 2013. A patient (no information was provided regarding the patient) had received an intradermal dose of DAPTACEL instead of TUBERSOL. The patient was then administered TB skin test at another side (administration site- not reported). No adverse event was reported. Documents held by sender: None.
pain radiating up arm/neck about an hour after injection (excruciating at times), unable to lift arm very high at all w/o pain, not able to sleep on left side.  Pain & stiffness continued to worsen over next several days. Still extremely sore & hard to lift /use my left arm 10 days later w/o pain
Immediately after receiving immunization vomited x 3 and c/o abdominal pain then within 10-15 minutes turned red all over body and felt chills. Epi-pen Jr given along with BENADRYL 2 tsp.
Palpitations felt after 15-20 minutes, subsided within 15 minutes.  Fatigue set in after 4-5 hours.  Fever the following morning to 100.8 F. Fever accompanied with dizziness and lightheadedness, syncopal event with brief LOC.  Overwhelming fatigue until 3:30 pm the following day, with arm pain.  On day #3 arm pain persisted, new development of neck pain and mild truncal rash.
Experienced some pain at the injection site after receiving the booster shoot on the right arm.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Experienced some pain at the injection site after receiving the booster shoot on the right arm.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Lymphadenectomy (The lymph nodes of the under the arm removed due to cancer treatment a few year ago.). Concurrent medical conditions included Cancer.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Experienced some pain at the injection site after receiving the booster shoot on the right arm.). At the time of the report, VACCINATION SITE PAIN (Experienced some pain at the injection site after receiving the booster shoot on the right arm.) outcome was unknown.            Concomitant medications details were not reported by the reporter.  Treatment details was not reported by the reporter.
Patient c/o dizziness and wanted to pass out.  Patient felt nervous when it comes to needle and report that happened in the past. Vital was taken BP: 129/82, HR: 60, Oxygen: 98. Nurse attended and gave patient 2 ice packs. Patient was observed longer and cleared by nurse.
Day One had sore arm, felt good enough to go to school, normal day. Day Two Woke up with fever of 102 complained of hoarse voice/sore throat, Tired. At the end of the day around 48 hours started deep coughing Day Three Fevers off and on all day, Fatigue off and on all day, Lack of appetite, Cough is worse, Voice is very hoarse and raspy. Day Four Fevers continue to be off and on all day 99.9 to 102 all day, still lack of appetite, voice is hoarse, says it hurts at base of throat,  cough is still very deep and hurts. complaining of pain/pressure in upper chest area (like a big hug on his chest) coloring is off,  around dinner time, looks very pale and tired. Day Five Fevers everything is the same as yesterday, take him to Doctor's office to be looked at by a doctor.
SHORTNESS OF BREATH; fever blisters on upper lip; flu-like symptoms; Dizziness; Fever; Tender arm; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of TENDERNESS (Tender arm), DYSPNOEA (SHORTNESS OF BREATH), LIP BLISTER (fever blisters on upper lip), INFLUENZA LIKE ILLNESS (flu-like symptoms) and DIZZINESS (Dizziness) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0461321A and 047A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LOSARTAN, MONTELUKAST SODIUM (SINGULAIR), CLOPIDOGREL BISULFATE (PLAVIX) and HYDROCODONE BITARTRATE, PARACETAMOL (HYDROCODONE/ACETAMINOPHEN) for an unknown indication.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Mar-2021, the patient experienced TENDERNESS (Tender arm). On 15-Apr-2021, the patient experienced DYSPNOEA (SHORTNESS OF BREATH), LIP BLISTER (fever blisters on upper lip), INFLUENZA LIKE ILLNESS (flu-like symptoms), DIZZINESS (Dizziness) and PYREXIA (Fever). On 13-May-2021, DYSPNOEA (SHORTNESS OF BREATH), LIP BLISTER (fever blisters on upper lip), INFLUENZA LIKE ILLNESS (flu-like symptoms), DIZZINESS (Dizziness) and PYREXIA (Fever) had resolved. At the time of the report, TENDERNESS (Tender arm) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-127725 (Patient Link).
sores in her mouth; mouth became inflamed her dentist said it was probably thrush; This spontaneous case was reported by a consumer and describes the occurrence of ORAL CANDIDIASIS (mouth became inflamed her dentist said it was probably thrush) and STOMATITIS (sores in her mouth) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 immunisation.     Concurrent medical conditions included Burning tongue. Concomitant products included ATENOLOL, ATORVASTATIN, OMEPRAZOLE, VITAMINS NOS and HYDROCHLOROTHIAZIDE for an unknown indication.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced ORAL CANDIDIASIS (mouth became inflamed her dentist said it was probably thrush). On an unknown date, the patient experienced STOMATITIS (sores in her mouth). The patient was treated with NYSTATIN at an unspecified dose and frequency. At the time of the report, ORAL CANDIDIASIS (mouth became inflamed her dentist said it was probably thrush) and STOMATITIS (sores in her mouth) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Slight cough and runny nose 10/6/21  lack of energy  and poor appetite has been going on for a few months.
lymph node being swollen; pain under her arm pit; inflammation and the pain in the armpit; under my arm by the armpit it was all swollen and it is still but the swelling has gone down then yesterday; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 33 year-old female patient received bnt162b2 (BNT162B2), administration date 08Oct2021 (Lot number: FF8839, Expiration Date: Dec2021) at the age of 33 years as dose 3 (booster), single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1; MANUFACTUERER UNKNOWN), for Covid-19 Immunization; Bnt162b2 (DOSE 2; MANUFACTUERER UNKNOWN), for Covid-19 Immunization. The following information was reported: LYMPHADENOPATHY (non-serious) with onset Oct2021, outcome "unknown", described as "lymph node being swollen"; AXILLARY PAIN (non-serious) with onset Oct2021, outcome "unknown", described as "pain under her arm pit"; INFLAMMATION (non-serious) with onset Oct2021, outcome "unknown", described as "inflammation and the pain in the armpit"; SWELLING (non-serious) with onset Oct2021, outcome "recovering", described as "under my arm by the armpit it was all swollen and it is still but the swelling has gone down then yesterday". Therapeutic measures were not taken as a result of lymphadenopathy, axillary pain, inflammation, swelling.  Additional information: Caller stated that she received the booster dose of the Pfizer COVID-19 vaccine last Friday and after the third or booster dose, "within 24 to 48 hours", she experienced severe swelling and pain under her arm pit". She also stated that initially, she "already had swelling and pain under her arm pit". Caller stated that she was aware of information on lymph node being swollen. She was already advised by her HCP to have a mammogram done or breast cancer test done and contacted CDC and they stated to follow her HCP's recommendations. It was reported that initially she already had swelling, and pain and she was recommended to have a mammogram done by her healthcare provider. Patient did not receive any vaccine prior to this. Consumer stated, no it was not at the site of injection, I was not feeling at site of the injection but inflammation and the pain in the armpit, so under my arm by the armpit it was all swollen and it was still but the swelling has gone down then yesterday.  No follow-up attempts are possible. No further information is expected.